| Literature DB >> 30175114 |
Nasser M Al-Daghri1, Ihtisham Bukhari1, Sobhy M Yakout1, Shaun Sabico1, Malak N K Khattak1, Ibrahim Aziz1, Majed S Alokail1.
Abstract
INTRODUCTION: Nitric oxide (NOx) is an important biomolecule which interacts with other molecules including 25(OH)D to mediate various metabolic pathways. Interactions and associations of NOx with 25(OH)D have been well studied both in vitro and in vivo, yet associations in apparently healthy adolescents have never been studied.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30175114 PMCID: PMC6098934 DOI: 10.1155/2018/1489132
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Clinical characteristics of the subjects.
|
|
|
|
|
|
|---|---|---|---|---|
|
| 740 | 245 (33.1) | 495 (66.9) | |
| Age (years) | 14.2 ± 1.6 | 14.1 ± 1.2 | 14.3 ± 1.8 | 0.18 |
|
| ||||
| Body Mass Index (kg/m2) | 21.9 ± 4.8 | 22.7 ± 4.4 | 21.5 ± 4.9 |
|
|
| ||||
| Waist circumference (cm) | 73.6 ± 11.7 | 72.2 ± 10.0 | 74.7 ± 12.8 |
|
|
| ||||
| Hip circumference (cm) | 88.0 ± 11.2 | 92.8 ± 10.1 | 84.3 ± 10.6 |
|
|
| ||||
| WHR | 0.8 ± 0.09 | 0.8 ± 0.1 | 0.9 ± 0.1 |
|
|
| ||||
| Systolic BP (mmHg) | 119.4 ± 14.0 | 116.0 ± 13.0 | 121.0 ± 14.2 |
|
|
| ||||
| Diastolic BP (mmHg) | 70.1 ± 9.8 | 72.6 ± 10.2 | 68.9 ± 9.3 |
|
|
| ||||
| Glucose (mmol/l) | 5.1 ± 0.7 | 4.9 ± 0.8 | 5.2 ± 0.7 |
|
|
| ||||
| Triglycerides (mmol/l)# | 1.0 (0.8-1.4) | 1.0 (0.8-1.4) | 1.0 (0.8-1.4) | 0.62 |
|
| ||||
| Total Cholesterol (mmol/l) | 4.3 ± 1.0 | 4.0 ± 1.1 | 4.4 ± 0.9 |
|
|
| ||||
| HDL-Cholesterol (mmol/l) | 1.2 ± 0.4 | 1.0 ± 0.2 | 1.3 ± 0.4 |
|
|
| ||||
| LDL-Cholesterol (mmol/l) | 2.6 ± 0.8 | 2.6 ± 0.8 | 2.6 ± 0.8 |
|
|
| ||||
| LDL/HDL ratio | 2.5 ± 1.2 | 2.7 ± 0.9 | 2.4 ± 1.3 |
|
|
| ||||
| 25(OH)D (nmol/l)# | 33.6 (24.9-46.6) | 25.6 (20.2-32.2) | 38.6 (29.7-50.2) |
|
|
| ||||
| Nitric Oxide ( | 12.8 (5.7-26.4) | 21.9 (12.8-37.5) | 9.3 (5.0-20.0) |
|
Note: data is presented as N (%) for frequencies and mean ± standard deviation for normal continuous variables; # denotes non-Gaussian variables presented as median (25th-75th) percentiles; P-value is significant at 0.05.
Figure 1Data is presented in median (1st-3rd) percentiles. ∗∗∗ represents overall significance at 0.01 level.
Association between NOx and other parameters.
|
|
|
|
|
|---|---|---|---|
| N (%) | 740 | 245 (33.1) | 495 (66.9) |
|
| |||
| Age (years) | 0.01 | 0.25∗∗ | 0.06 |
|
| |||
| Body Mass Index (kg/m2) | 0.10∗ | 0.07 | 0.04 |
|
| |||
| Waist circumference (cm) | 0.09∗ | 0.03 | 0.10 |
|
| |||
| Hip circumference (cm) | 0.20∗∗ | 0.03 | 0.12∗ |
|
| |||
| WHR | -0.12∗∗ | -0.04 | 0.04 |
|
| |||
| Systolic Blood Pressure (mmHg) | 0.11∗∗ | 0.33∗∗ | 0.13∗∗ |
|
| |||
| Diastolic Blood Pressure (mmHg) | 0.10∗ | -0.04 | 0.08 |
|
| |||
| Glucose (mmol/l) | -0.06 | -0.03 | 0.03 |
|
| |||
| Triglycerides (mmol/l)# | 0.26∗∗ | 0.25∗∗ | 0.31∗∗ |
|
| |||
| Total Cholesterol (mmol/l) | -0.36∗∗ | -0.38∗∗ | -0.29∗∗ |
|
| |||
| LDL-Cholesterol (mmol/l) | -0.22∗∗ | -0.11 | -0.26∗∗ |
|
| |||
| LDL/HDL ratio | 0.07 | 0.15∗ | -0.01 |
|
| |||
| HDL-Cholesterol (mmol/l) | -0.38∗∗ | -0.38∗∗ | -0.27∗∗ |
|
| |||
| 25(OH)D (nmol/l)# | -0.21∗∗ | 0.04 | -0.37∗∗ |
Note: data is presented as coefficient (R); # denotes log transform; ∗ denotes significance at 0.05 level; ∗∗ denotes significance at 0.01 level.
Clinical characteristics of the subject.
|
|
|
|
|
|
|---|---|---|---|---|
| N (%) | 186 (25.1) | 418 (56.5) | 136 (18.4) | |
| Age (years) | 14.5 ± 1.5 | 14.2 ± 1.5 | 13.4 ± 1.8 | <0.001 |
|
| ||||
| Body Mass Index (kg/m2) | 22.7 ± 4.8 | 22.0 ± 4.7 | 19.9 ± 3.9 | <0.001 |
|
| ||||
| Waist circumference (cm) | 73.0 ± 10.8 | 74.3 ± 11.7 | 70.0 ± 12.1! | 0.010 |
|
| ||||
| Hip circumference (cm) | 91.0 ± 10.8 | 87.5 ± 9.7 | 80.5 ± 11.3 | <0.001 |
|
| ||||
| WHR | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.9 ± 0.1 | <0.001 |
|
| ||||
| Systolic BP (mmHg) | 119.1 ± 14.5 | 119.9 ± 13.2 | 117.2 ± 15.4 | 0.23 |
|
| ||||
| Diastolic BP (mmHg) | 72.2 ± 10.1 | 69.9 ± 9.4 | 68.2 ± 9.6 | 0.005 |
|
| ||||
| Glucose (mmol/l) | 5.1 ± 0.8 | 5.2 ± 0.7 | 5.0 ± 0.6 | 0.12 |
|
| ||||
| Triglycerides (mmol/l)# | 1.1 (0.8-1.5) | 1.0 (0.8-1.3) | 1.0 (0.8-1.3) | 0.13 |
|
| ||||
| Total Cholesterol (mmol/l) | 4.1 ± 1.1 | 4.3 ± 1.0 | 4.5 ± 1.0 | 0.015 |
|
| ||||
| HDL-Cholesterol (mmol/l) | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 0.42 |
|
| ||||
| LDL-Cholesterol (mmol/l) | 2.5 ± 0.7 | 2.6 ± 0.8 | 2.7 ± 0.9 | 0.22 |
|
| ||||
| LDL/HDL ratio | 2.4 ± 0.9 | 2.4 ± 1.2 | 2.6 ± 1.5 | 0.17 |
|
| ||||
| 25(OH)D (nmol/l)# | 20.4 (18.3-22.5) | 35.1 (30.0-49.5) | 59.8 (53.2-65.5) | <0.001 |
|
| ||||
| Nitric Oxide ( | 18.0 (8.9-33.5) | 12.9 (5.2-25.4) | 7.4 (4.4-12.7) | <0.001 |
Note: data is presented as N (%) for frequencies and mean ± standard deviation for normal continuous variables; # denotes continuous variables with non-Gaussian distribution presented as median (25th-75th) percentiles; P-value is significant at 0.05 and 0.01. “∗” denotes significance compared to deficient; “!” denotes significance compared to insufficient.
Association between nitric oxide with other parameters according to vitamin D status.
|
|
|
|
|
|---|---|---|---|
| N | 186 (25.1) | 418 (56.5) | 136 (18.4) |
|
| |||
| Age (years) | 0.03 | -0.003 | 0.08 |
|
| |||
| Body Mass Index (kg/m2) | -0.01 | 0.06 | 0.04 |
|
| |||
| Waist circumference (cm) | 0.05 | -0.04 | 0.10 |
|
| |||
| Hip circumference (cm) | 0.05 | 0.17∗∗ | 0.05 |
|
| |||
| WHR | -0.003 | -0.26∗∗ | 0.14 |
|
| |||
| Systolic BP (mmHg) | 0.11 | 0.11∗∗ | 0.08 |
|
| |||
| Diastolic BP (mmHg) | 0.13 | 0.10 | -0.12 |
|
| |||
| Glucose (mmol/l) | -0.03 | -0.08 | -0.05 |
|
| |||
| Triglycerides (mmol/l)# | 0.20∗ | 0.32∗∗ | 0.24∗ |
|
| |||
| Total Cholesterol (mmol/l) | -0.36∗∗ | -0.34∗∗ | -0.26∗∗ |
|
| |||
| HDL-Cholesterol (mmol/l) | -0.39∗∗ | -0.41∗∗ | -0.22∗∗ |
|
| |||
| LDL-Cholesterol (mmol/l) | -0.19∗ | -0.18∗∗ | -0.29∗∗ |
|
| |||
| LDL/HDL ratio | 0.21∗ | 0.11 | -0.09 |
|
| |||
| 25(OH)D (nmol/l)# | 0.06 | -0.04 | -0.04 |
Note: data is presented as coefficient (R); # denotes log transform; ∗ denotes significance at 0.05 level; ∗∗ denotes significance at 0.01 level.
Figure 2Data is presented in median (1st-3rd) percentiles. ∗∗∗ represents overall significance at 0.01 level; ∗∗ represents significance between deficient and insufficient ones at 0.01 level.